Skip to content

TRV GP IV, LLC

Follow

13F filer, CIK 1688325, Boston, MA

TRV GP IV, LLC reported $92,850,581 across 3 holdings for the quarter ended 2025-03-31, in a 13F-HR filed 2025-05-09.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-25-004486

Period
2025-03-31
Reported value
$92.9M
Holdings
3
Top 10 weight
100%
New
1
Sold out
0

Largest buys vs the previous quarter

SecurityShares changeApprox. value
MAZEnew+6,073,958$66.9M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

None.

Holdings, Q1 2025

Share positions as resolved from 13F-HR 0000950123-25-004486, largest first. % of portfolio is the value over $92,850,581, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
MAZEMAZE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 6,073,958 shares 6,073,958$66.9M72.02%newTimeline
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 16,859,075 shares; 2024Q4: 16,859,075 shares; 2025Q1: 16,859,075 shares 16,859,075$23.1M24.88%0Timeline
PLRXPLIANT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,132,867 shares; 2024Q4: 2,132,867 shares; 2025Q1: 2,132,867 shares 2,132,867$2.88M3.1%0Timeline

How Q1 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000950123-25-004486 base2025-05-09acceptance time not in the bulk data set